IGM Biosciences (IGMS) Short Interest Ratio & Short Volume → Exposed: 10 CENT Crypto to Explode April 20th? (From True Market Insiders) (Ad) Free IGMS Stock Alerts $7.65 -0.31 (-3.89%) (As of 04/25/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability IGM Biosciences Short Interest DataCurrent Short Volume5,250,000 sharesPrevious Short Volume5,220,000 sharesChange Vs. Previous Month+0.57%Dollar Volume Sold Short$49.40 millionShort Interest Ratio / Days to Cover19.4Last Record DateApril 15, 2024Outstanding Shares58,790,000 sharesFloat Size20,970,000 sharesShort Percent of Float25.04%Today's Trading Volume546,345 sharesAverage Trading Volume287,310 sharesToday's Volume Vs. Average190% Short Selling IGM Biosciences ? Sign up to receive the latest short interest report for IGM Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatIGMS Short Interest Over TimeIGMS Days to Cover Over TimeIGMS Percentage of Float Shorted Over Time Ad Colonial MetalsThe Gold Grab of the CenturyWhen central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.That's why we have released our Free Precious Metals Investment Guide. IGM Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20245,250,000 shares $49.40 million +0.6%25.0%19.4 $9.41 3/31/20245,220,000 shares $50.37 million +9.7%25.1%18.5 $9.65 3/15/20244,760,000 shares $50.65 million +5.5%22.9%16.4 $10.64 2/29/20244,510,000 shares $56.96 million -1.3%21.4%14.5 $12.63 2/15/20244,570,000 shares $70.38 million -2.6%21.9%14 $15.40 1/31/20244,690,000 shares $49.34 million -4.1%22.5%15.3 $10.52 Get the Latest News and Ratings for IGMS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for IGM Biosciences and its competitors with MarketBeat's FREE daily newsletter. 1/15/20244,890,000 shares $53.50 million +4.7%23.5%14.2 $10.94 12/31/20234,670,000 shares $38.81 million +7.9%22.4%13.2 $8.31 12/15/20234,330,000 shares $28.58 million +5.4%20.9%12.5 $6.60 11/30/20234,110,000 shares $27.70 million -1.0%19.8%12.6 $6.74 11/15/20234,150,000 shares $24.49 million -17.0%20.0%13.9 $5.90 10/31/20235,000,000 shares $19.70 million -6.2%24.1%17.2 $3.94 10/15/20235,330,000 shares $23.51 million +1.5%25.7%20.6 $4.41 9/30/20235,250,000 shares $43.84 million -6.6%25.3%22.1 $8.35 9/15/20235,620,000 shares $41.36 million -0.4%27.1%21.3 $7.36 8/31/20235,640,000 shares $40.33 million +2.9%28.2%19 $7.15 8/15/20235,480,000 shares $42.74 million +12.3%27.4%17.1 $7.80 7/31/20234,880,000 shares $51.92 million -1.6%24.3%15.2 $10.64 7/15/20234,960,000 shares $49.60 million +2.3%26.1%15.8 $10.00 6/30/20234,850,000 shares $44.77 million +8.3%26.3%14.3 $9.23 6/15/20234,480,000 shares $45.07 million +2.5%24.2%13.4 $10.06 5/31/20234,370,000 shares $52.66 million +5.1%24.8%16.3 $12.05 5/15/20234,160,000 shares $57.32 million +2.5%23.7%18 $13.78 4/30/20234,060,000 shares $43.97 million +3.3%23.3%17.9 $10.83 4/15/20233,930,000 shares $43.66 million +7.4%22.8%18.2 $11.11 3/31/20233,660,000 shares $50.29 million -0.5%21.2%16.1 $13.74 3/15/20233,680,000 shares $69.59 million +3.7%21.1%20.5 $18.91 2/28/20233,550,000 shares $74.62 million -2.2%20.3%18.1 $21.02 2/15/20233,630,000 shares $87.05 million -4.5%20.8%17.4 $23.98 1/31/20233,800,000 shares $86.37 million +5.0%21.8%16.2 $22.73 1/15/20233,620,000 shares $91.69 million +4.3%20.9%15.1 $25.33 12/30/20223,470,000 shares $59.02 million -4.7%20.0%16 $17.01 12/15/20223,640,000 shares $67.34 million +12.7%20.9%15.8 $18.50 11/30/20223,230,000 shares $71.09 million -9.3%18.7%14.9 $22.01 11/15/20223,560,000 shares $92.63 million +5.6%20.6%16.2 $26.02 10/31/20223,370,000 shares $67.40 million -2.3%19.5%17.4 $20.00 10/15/20223,450,000 shares $71.35 million +3.6%19.9%18 $20.68 9/30/20223,330,000 shares $75.72 million +3.4%19.2%17 $22.74 9/15/20223,220,000 shares $71.55 million -3.9%18.6%16.2 $22.22 8/31/20223,350,000 shares $65.02 million +3.1%20.1%15.3 $19.41The Hard Truth About Investing For Retirement (Ad)Here’s the cold, hard truth about investing: The more capital you have, the more risk averse you can afford to be. But when you’re staring down the barrel of retirement and you’ve only got 5, 10, 50 or $100,000 saved, you’ve got to be more aggressive. In an exclusive online training, the Market expert Steven Place is revealing a powerful “roadmap” that’s leading everyday investors to easy, triple-digit wins, even if they don’t have a lot of experience in trading.Click To Access This Powerful Training Right Now! IGMS Short Interest - Frequently Asked Questions What is IGM Biosciences' current short interest? Short interest is the volume of IGM Biosciences shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 5,250,000 shares of IGMS short. 25.04% of IGM Biosciences' shares are currently sold short. Learn More on IGM Biosciences' current short interest. What is a good short interest ratio for IGM Biosciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. IGMS shares currently have a short interest ratio of 19.0. Learn More on IGM Biosciences's short interest ratio. Which institutional investors are shorting IGM Biosciences? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of IGM Biosciences: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for IGM Biosciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 25.04% of IGM Biosciences' floating shares are currently sold short. Is IGM Biosciences' short interest increasing or decreasing? IGM Biosciences saw a increase in short interest in April. As of April 15th, there was short interest totaling 5,250,000 shares, an increase of 0.6% from the previous total of 5,220,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is IGM Biosciences' float size? IGM Biosciences currently has issued a total of 58,790,000 shares. Some of IGM Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. IGM Biosciences currently has a public float of 20,970,000 shares. How does IGM Biosciences' short interest compare to its competitors? 25.04% of IGM Biosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to IGM Biosciences: Acelyrin, Inc. (12.80%), Shattuck Labs, Inc. (4.42%), Theravance Biopharma, Inc. (14.72%), Adlai Nortye Ltd. (0.02%), Fulcrum Therapeutics, Inc. (4.07%), Travere Therapeutics, Inc. (15.50%), Entrada Therapeutics, Inc. (9.71%), Applied Therapeutics, Inc. (4.15%), KalVista Pharmaceuticals, Inc. (13.79%), Avid Bioservices, Inc. (16.32%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short IGM Biosciences stock? Short selling IGMS is an investing strategy that aims to generate trading profit from IGM Biosciences as its price is falling. IGMS shares are trading down $0.83 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against IGM Biosciences? A short squeeze for IGM Biosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of IGMS, which in turn drives the price of the stock up even further. How often is IGM Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IGMS, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: SLRN Short Squeeze STTK Short Squeeze TBPH Short Squeeze ANL Short Squeeze FULC Short Squeeze TVTX Short Squeeze TRDA Short Squeeze APLT Short Squeeze KALV Short Squeeze CDMO Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:IGMS) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss RatingsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThe AI stock to buy right nowStockEarnings